A huntingtin-associated protein enriched in brain with implications for pathology

Area of Science:

• Neurodegenerative disorders
• Genetics of neurodegeneration
• Molecular biology of Huntington's disease

Background:

• Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
• Caused by expanded polyglutamine repeats in the huntingtin gene (IT15).
• HD pathology is selectively confined to the brain, despite widespread huntingtin gene expression.

Purpose of the Study:

• To identify proteins interacting with huntingtin.
• To investigate the role of these interactions in the selective brain pathology of HD.
• To understand how expanded polyglutamine repeats affect huntingtin interactions.

Main Methods:

• Protein identification and binding assays.
• Analysis of huntingtin-associated protein (HAP)-1 interaction with huntingtin.
• Correlation of HAP-1 binding with polyglutamine repeat length.

Main Results:

• Identification of huntingtin-associated protein (HAP)-1, a novel huntingtin-binding protein.
• HAP-1 binding to huntingtin is enhanced by expanded polyglutamine repeats.
• HAP-1 is notably enriched in brain tissue.

Conclusions:

• HAP-1 binding to huntingtin may be implicated in the selective brain pathology of Huntington's disease.
• The enhanced binding of HAP-1 with expanded repeats suggests a mechanism for HD pathogenesis.
• HAP-1 represents a potential therapeutic target for Huntington's disease.